Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179546 | SCV000231808 | likely benign | not specified | 2014-12-16 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000179546 | SCV000270580 | benign | not specified | 2017-05-09 | criteria provided, single submitter | clinical testing | p.Ile431Ile in exon 7 of MYPN: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.6% (62/10150) of Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http:// gnomad.broadinstitute.org/; dbSNP rs147184158). |
Ambry Genetics | RCV000254353 | SCV000317563 | likely benign | Cardiovascular phenotype | 2015-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000179546 | SCV000516172 | benign | not specified | 2015-10-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000457882 | SCV000563306 | likely benign | Dilated cardiomyopathy 1KK | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000457882 | SCV000745046 | likely benign | Dilated cardiomyopathy 1KK | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000179546 | SCV003928618 | benign | not specified | 2023-04-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001723754 | SCV004126619 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | MYPN: BP4, BS1 |
Prevention |
RCV003937625 | SCV004747705 | likely benign | MYPN-related disorder | 2019-08-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000457882 | SCV000732946 | likely benign | Dilated cardiomyopathy 1KK | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000179546 | SCV001919419 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723754 | SCV001952560 | likely benign | not provided | no assertion criteria provided | clinical testing |